HLS Therapeutics Inc (TSX:HLS)
C$ 4.42 -0.050 (-1.12%) Market Cap: 138.24 Mil Enterprise Value: 182.98 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 62/100

HLS Therapeutics Inc (TSX:HLS) Transcripts

  • 1